Brain Health - Guidelines, Grant Fund, and Commemorative Month (Tahjai's Law)
HB0825, titled the Brain Health – Guidelines, Grant Fund, and Commemorative Month (Tahjai’s Law), would create a new state framework focused on brain health awareness, screening, and support services. It requires the Governor to proclaim May as Brain Health and Chronic Headache Awareness Month each year, aligned with national Go Gray in May brain tumor awareness initiatives. The bill also directs the Maryland Department of Health to develop guidelines for incorporating risk-based brain health evaluations into routine physicals and wellness visits, including possible neurological assessments, evidence-based decision tools, and referral protocols for noninvasive imaging.
The bill further establishes the Maryland Brain Health Grant Fund as a special, nonlapsing fund to support grants for nonprofits, health care providers, local health departments, and community-based programs. Those grants would be used for brain health awareness, screening, prevention, and services related to brain tumors, chronic headaches, migraines, traumatic brain injury, cerebrovascular conditions, and other neurological pain disorders. The Department would administer the fund, set transparent grant criteria, prioritize underserved communities, and report annually on fund use and statewide brain health data.
HB0825 would add new provisions to Maryland’s General Provisions and Health – General Articles, creating a commemorative month designation, a new state grant fund, and a set of Department of Health duties related to brain health guidelines, reporting, and recommendations. It would require annual reporting on brain tumor and chronic headache prevalence, emergency department visits, access to diagnostic imaging, and barriers to care, and it would direct the Department to study screening intervals and insurance coverage parity for medically necessary brain health diagnostic tools. The bill also requires a $500,000 appropriation to the new fund in fiscal year 2028 and sets an effective date of July 1, 2026.
The available context suggests generally supportive sentiment, as reflected by the bill’s broad list of House sponsors and its framing around awareness, access to care, and support for patients with neurological conditions. No committee transcript or recorded votes were provided, so there is no evidence in the supplied materials of formal opposition or amendment debate. The bill appears to be presented as a public health and awareness measure with a patient-support focus.
The main potential points of contention are likely fiscal and administrative rather than conceptual. The bill creates a new special fund, requires a future $500,000 budget appropriation, and directs the Department of Health to develop guidelines, recommendations, and annual reports, which could raise questions about implementation costs and agency workload. Another possible issue is the bill’s recommendation on insurance coverage parity for medically necessary diagnostic tools, which may draw scrutiny from payors or budget-conscious lawmakers. The bill also specifies consultation with the Solid Foundation, Inc., clinical experts, and patient advocacy groups, indicating that stakeholder input and the scope of the fund’s uses may be important areas of discussion.